How I treat Rett syndrome with trofinetide: changes in dosing frequency and administration with rice cereal
Bibliographic record
Abstract
Trofinetide is the first and only medication approved for the treatment for Rett syndrome (RTT) in patients aged ≥2 years in the US and Canada. Trofinetide is disease-specific and improves the core symptoms of RTT. The most common adverse event reported in trofinetide clinical trials was diarrhea. Recommendations for the management of diarrhea with trofinetide include lifestyle and pharmacological interventions. Clinicians and caregivers of patients with RTT remain interested in additional diarrhea management strategies to avoid treatment discontinuation. Here, I present the rationale for how changing the trofinetide dosing schedule from the recommended twice a day dosing to three or four times a day, with or without rice cereal, can mitigate the incidence of diarrhea with trofinetide without the use of antidiarrheal medications. The rationale for these changes is supported by the presentation of three anecdotal cases from my clinical practice. In all patient cases, the change of dosing schedule or the addition of rice cereal resolved the incidence of diarrhea, allowing for treatment continuation and improvement in RTT symptoms. These experiences suggest that the incidence of diarrhea can be improved by changing the trofinetide dosing schedule with or without the addition of rice cereal without negative impact to efficacy.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.001 | 0.004 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.001 |
| Bibliometrics | 0.000 | 0.000 |
| Science and technology studies | 0.001 | 0.001 |
| Scholarly communication | 0.001 | 0.002 |
| Open science | 0.001 | 0.000 |
| Research integrity | 0.002 | 0.003 |
| Insufficient payload (model declined to judge) | 0.004 | 0.002 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".